FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, namely clinical pharmacology, and may be used for pharmacological correction of the CNS disease, and concerns the agents showing anxiolytic action. The ingredients of the composition have the following relation, wt %: Magnesium sulphate 77.76835-50.22505; Ferric (II) sulphate 13.73-30.27; Copper (II) sulphate 8.50-19.50; Chromium (III) chloride 0.00165-0.00495.
EFFECT: developing the agents showing anxiolytic action.
3 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
PSYCHOSTIMULANT AGENT | 2010 |
|
RU2438677C1 |
NOOTROPIC AGENT | 2011 |
|
RU2475250C1 |
AGENT POSSESSING ANXIOLYTIC ACTIVITY | 2015 |
|
RU2571286C1 |
QUINAZOLINE DERIVATIVES, POSSESSING ANTIDEPRESSANT, ANXIOLYTIC AND NOOTROPIC ACTIVITY | 2012 |
|
RU2507199C1 |
MEDICATION, POSSESSING ANXIOLYTIC ACTIVITY | 2013 |
|
RU2519191C1 |
2-ETHYL-6-METHYL-3-OXYPYRODINE SALTS WITH ORGANIC CARBOXYLIC ACIDS POSSESSING ANXIOLYTIC, ANTIDEPRESSIVE, ANTIHYPOXIC, ANTI-AMNESTIC AND ANTI-OXIDATIVE ACTIVITY AND METHOD FOR THEIR PREPARING | 2002 |
|
RU2284993C2 |
AGENT POSSESSING ANXIOLYTHIC ACTION, ON BASIS OF HYDROGENATED PYRIDO (4,3-b) INDOLES (VERSIONS), PHARMACOLOGICAL AGENT ON ITS BASIS AND WAY OF ITS APPLICATION | 2007 |
|
RU2338533C1 |
PHARMACEUTICAL FORMULATION POSSESSING CEREBROPROTECTIVE AND ANTINEUROTIC ACTION | 2013 |
|
RU2535024C1 |
ANXIOLYTIC AGENT | 2007 |
|
RU2354397C1 |
ANXIOLYTIC HERBAL TEA | 2014 |
|
RU2565452C1 |
Authors
Dates
2012-10-27—Published
2011-10-20—Filed